BRIAN BERGER
Allopathic & Osteopathic Physicians|Radiology|Radiation Oncology NEWTON, KS NPI 1003852385
Browse related groups: Allopathic & Osteopathic Physicians|Radiology|Radiation Oncology KS NOVARTIS PHARMACEUTICALS CORPORATION All categories
General Payments — all program years on this page
$446.90
- Category: General Payments
- Program years: PY2018–2019
- Record count: 29
- As of (CMS publication): 2026-01-23
Latest program year (PY2019): $85.40 across 6 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2019) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $85.40 | 6 |
By paying entity
Latest program year (PY2019) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $27.18 | 2 |
| Pharmacyclics LLC, An AbbVie Company | $17.18 | 1 |
| E.R. Squibb & Sons, L.L.C. | $16.02 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $12.98 | 1 |
| Merck Sharp & Dohme Corporation | $12.04 | 1 |
By program year
Records — PY2019 (6)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 651219747 | E.R. Squibb & Sons, L.L.C. | $16.02 | 02/14/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 658864201 | Novartis Pharmaceuticals Corporation | $11.76 | 01/31/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 658864207 | Novartis Pharmaceuticals Corporation | $15.42 | 02/28/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 665713665 | Pharmacyclics LLC, An AbbVie Company | $17.18 | 12/16/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 695277749 | Merck Sharp & Dohme Corporation | $12.04 | 02/19/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 697404957 | Takeda Pharmaceuticals U.S.A., Inc. | $12.98 | 08/27/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2019_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.